Reaction

Therapy Responder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 487 reports · 7 co-occurring drugs

As of the last recalculation, Therapy Responder appears in 487 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BENDAMUSTINE HYDROCHLORIDE (PRR 55.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Bendamustine Hydrochloride1555.255.3
Cannabidiol1324.424.4
Fludarabine Phosphate2123.823.8
Cisplatin3520.620.6
Bevacizumab5019.119.1
Sofosbuvir613.113.2
Peginterferon Alfa-2A1613.013.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.